Thursday, May 12, 2016

World’s Highest Paid CEO Makes His Killing from Cancer Patients


Soon-Shiong-1

Natural and affordable cancer remedies seem to be continually ignored by the mainstream cancer industry as alternatives to chemo, radiation and designer drugs, because of one simple fact: cancer and cancer research is a huge industry. According to Bloomberg’s rankings, the highest paid chief corporate officer is Patrick Soon-Shiong, CEO of NantKwest Inc., a cancer research company, which delivered him a $147.6 million pay package in 2015. That’s more than the CEO of Google, who took home a whopping $100.5 million last year.
The Bloomberg Billionaires Index reveals that Soon-Shiong’s net worth is $9.8 billion. His company NantKwest went public in 2015, and now Soon-Shiong’s compensation is tied to reaching “strategic milestones.” Does that mean actually finding a cure? Maybe the company’s marketing team will tell you so, but typically, milestones for publicly traded companies are exclusively tied to revenue growth and profit.
As per its website, NantKwest’s approach to combating cancer is “focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases.” The company expects the Natural Killer treatment to be administered in an “outpatient setting as an ‘off-the-shelf’ living drug.” Their stated goal is to “change the current paradigm of cancer care,” and, let’s be honest, make billions along the way.
Considering Soon-Shiong’s history in the pharmaceutical industry, which turned him into a billionaire after the sale of his companies APP Pharmaceuticals and Abraxis BioScience Inc., NantKwest, as most cancer research corporations and pharmaceutical companies, is not likely to explore the many potential natural options to treat cancer, favoring instead the most complex. You can’t patent nature, so a natural cure wouldn’t make them much money. It is unlikely that any of the “strategic milestones” of the key players in this industry are to decrease revenues as a result of developing an effective cure for cancer with permanent effects, or to explore natural cancer treatments to make surviving cancer more affordable.
When an industry develops from a problem that problem will get worse, not better. ~ Unknown
Cancer is a big problem; there is no doubt about that. It comes as no surprise, considering that nearly all conventional products that we put on and into our bodies are filled with some concoction of synthetic and toxic chemicals. The environment is filled to the brim with toxic pollutants, from the type of materials we use to make cookware, to the chemicals being sprayed onto our food and into the air.
Humanity is desperate for a cancer cure as the statistics on cancer worsen every year. As people look to medical professionals for hope and guidance, little credit is given from the mainstream medical establishment to the natural and holistic approaches when it comes to preventing, treating and beating cancer, with food and other natural medicines.
The medical establishment seems to prey on frightened victims of cancer illness, faced with life or death, by directing them to expensive, profit driven pharmaceutical solutions. For example, chemotherapy, regardless of the question about its efficacy, can run anywhere from $7000 for initial treatment to $30,000 for an eight-week period. Some patients are faced with out of pocket expenses as high as $9000+ monthly for chemotherapy drugs.
The conventional approach to “finding the cure for cancer” is not working, but it does continue to perpetuate a lucrative industry, making some, like Patrick Soon-Shiong, immensely wealthy, at least in the material sense.            Walking Times

Sources:
http://www.bloomberg.com/news/articles/2016-04-27/billionaire-nantkwest-ceo-gets-148-million-pay-package-for-2015
http://www.huffingtonpost.com/erin-havel/high-costs-of-cancer-drug_b_7505558.html
http://www.asbestos.com/treatment/expenses.php

No comments:

Post a Comment